Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis.
The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by the mainstream in Europe and North America. Later, because people believed that its composition was unclear, quality control was difficult, and there were problems with abuse, it began to be gradually regulated and even banned. Since then, cannabis has become a plant that people are afraid of and stay away from. But now, we have to admit that cannabis has very important medicinal value.
Smoking
• Most common route of administration, but not recommended (joints, bongs, pipes, etc.)
• Combustion at 600–900 °C producing toxic biproducts: tar, PAH (polycyclic aromatic hydrocarbons), carbon monoxide (CO), ammonia (NH3).
• Chronic use associated with respiratory symptoms (bronchitis, cough, phlegm), but not lung cancer nor COPD (if cannabis only).
• Patients may mix with tobacco increasing respiratory/cancer risk
• 30–50% of cannabis is lost to ‘side-stream’ smoke
Vaporisation
• Heats cannabis at 160–230 °C. Reduced CO, but not complete elimination of PAH demonstrated to date.
• Vaporisation produces significantly less harmful biproducts vs. smoking.
• Decreased pulmonary symptoms reported compared to smoking.
Oral
• Oils, capsules and other po routes increasingly popular due to convenience and accuracy of dosing.
• Edibles (brownies/cookies) may be more difficult to dose.
• Juicing and cannabis teas do not allow for adequate decarboxylation of raw plant
• Nabiximols oromucosal spray is currently the only cannabis-based prescription that delivers standardised dosage of /THC in a 1:1 ratio with extensive research
• Tinctures and lozenges intermediate onset with limited research
Other routes
• Topicals ideal for localised symptoms (dermatological conditions, arthritis), with limited research evidence
• Suppositories possibly indicated for specific populations (cancer, GI symptoms, young/ elderly, etc.) with variable absorption. THChemisuccinate may allow for best absorption with limited research.
• Recreational routes include ‘shatter’, ‘dabs’, concentrates. Deliver very high doses of THC with high risk of euphoria, impairment, reinforcement, toxic psychosis, orthostatic hypotension. Inappropriate for medical application.
| The way of dosing | Smoking/Vaporizing | Oral | oral mucosal absorption | Topical administration |
| Onset of Effect/min | 5-10 | 60-180 | 15-45 | It depends on the situation |
| Time/h | 2-4 | 6-8 | 6-8 | It depends on the situation |
| Advantages | Fast-acting, for acute or paroxysmal symptoms (nausea/pain) | Less odor, easy to disperse, beneficial to chronic disease symptoms | A pharmaceutical form (nabiximols) is available. Its efficacy and safety have been documented | Small systemic effect, good for local symptoms |
| Limitations | Requires dexterity, vaporizers can be expensive, and not all are portable | Takes a long time to work | Expensive, availability is spotty | Only local effect |
As cannabis-based medicines return to mainstream use, the proper delivery of drugs is also a key factor. Clinicians must have a deeper understanding of their pharmacology, dosage, and administration to maximize their therapeutic potential and minimize related problems. Correctly understand and apply cannabis drugs, deepen their research in the medical field, and overcome more medical problems.
Reference:
1.Russo EB. The pharmacological history of Cannabis. In: Pertwee R, editor. Handbook of cannabinoids. Oxford, United Kingdom: Oxford University Press; 2014. p. 23–43.
2.Russo EB. History of cannabis and its preparations in saga, science and sobriquet. Chem Biodivers 2007;4:2624–48.
3.Flachenecker, P.; Henze, T.; Zettl, U. K. Nabiximols (THC Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. Eur Neurol 2014, 71 (5–6), 271–279. https://doi.org/10.1159/000357427.
4.National Academies of Sciences Engineering and Medicine (U.S.). Committee on the health effects of marijuana: an evidence review and research agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. 5.Washington, DC: the National Academies Press; 2017. p. 1. (online resource, xviii, 468 pages). 6. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;376:2011–20.
7. Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2012;2:e94.
8. Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 2013;38:2952–61.
9. Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry 1997;12:913–10.Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 2011;36:1219–26.
11.MacCallum, C. A.; Russo, E. B. Practical Considerations in Medical Cannabis Administration and Dosing. European Journal of Internal Medicine 2018, 49, 12–19. https://doi.org/10.1016/j.ejim.2018.01.004.
1. Medical Background of Atomizers Atomization technology has long been applied in the medical field, particularly in the treatment of respiratory conditions such as asthma and COPD. By converting active compounds into ultra-fine particles, atomizers deliver substances directly to the lungs for rapid absorption and high bioavailability.
August 1st, 20251. Medical Background of Atomizers Atomization technology has long been applied in the medical field, particularly in the treatment of respiratory conditions such as asthma and COPD. By converting active compounds into ultra-fine particles, atomizers deliver substances directly to the lungs for rapid absorption and high bioavailability.
August 1st, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025Abstract Inhalation drug delivery systems have been used in clinical practice for over half a century due to their efficient drug delivery properties. This paper systematically evaluates the pharmacological advantages of portable battery-powered nebulizers as a platform for cannabinoid inhalation. Studies indicate that, compared to traditional oral administration, the inhalation route via nebulization offers significant
July 4th, 2025Abstract Inhalation drug delivery systems have been used in clinical practice for over half a century due to their efficient drug delivery properties. This paper systematically evaluates the pharmacological advantages of portable battery-powered nebulizers as a platform for cannabinoid inhalation. Studies indicate that, compared to traditional oral administration, the inhalation route via nebulization offers significant
July 4th, 2025U.S. marijuana interest groups are sounding the alarm over a House Republican budget proposal that, if passed by Congress, would outright ban marijuana-derived THC products at the federal level, including so-called THCA flower. U.S. Rep. Andy Harris, a Maryland Republican who chairs a key subcommittee on the bill, said the proposal, the Agriculture, Rural Development,
July 6th, 2025U.S. marijuana interest groups are sounding the alarm over a House Republican budget proposal that, if passed by Congress, would outright ban marijuana-derived THC products at the federal level, including so-called THCA flower. U.S. Rep. Andy Harris, a Maryland Republican who chairs a key subcommittee on the bill, said the proposal, the Agriculture, Rural Development,
July 6th, 2025A study published in the journal Nutrients found that water-soluble cannabidiol products have higher absorption rates in the bloodstream compared to oil-based. Through water-soluble technology, cannabinoids like Delta 9 THC can be seamlessly incorporated into various solutions, such as beverages, energy drinks, sodas, or water. What is Water-Soluble THC?Cannabinoids like Delta 9 THC are typically hydrophobic, meaning
May 28th, 2025A study published in the journal Nutrients found that water-soluble cannabidiol products have higher absorption rates in the bloodstream compared to oil-based. Through water-soluble technology, cannabinoids like Delta 9 THC can be seamlessly incorporated into various solutions, such as beverages, energy drinks, sodas, or water. What is Water-Soluble THC?Cannabinoids like Delta 9 THC are typically hydrophobic, meaning
May 28th, 2025
